DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Virtual Booth

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

DIGITAL CONTENT

4 NEWS #PharmaBuzz

media
4 NEWS #PharmaBuzz

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

4DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Ampreloxetine [usan], Td-9855, 1227056-84-9, 19997ez42i, 4-(2-(2,4,6-trifluorophenoxymethyl)phenyl)piperidine, 4-[2-(2,4,6-trifluorophenoxymethyl)phenyl]piperidine

Molecular Formula

C₁₈H₁₈F₃NO

Molecular Weight

321.3 g/mol

InChI Key

TZIALEBTHQWNAO-UHFFFAOYSA-N

FDA UNII

19997EZ42I

Ampreloxetine is under investigation in clinical trial NCT03750552 (Clinical Effect of TD-9855 for Treating snOH in Subjects With Primary Autonomic Failure).

1 2D Structure

Ampreloxetine

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

4-[2-[(2,4,6-trifluorophenoxy)methyl]phenyl]piperidine

2.1.2 InChI

InChI=1S/C18H18F3NO/c19-14-9-16(20)18(17(21)10-14)23-11-13-3-1-2-4-15(13)12-5-7-22-8-6-12/h1-4,9-10,12,22H,5-8,11H2

2.1.3 InChI Key

TZIALEBTHQWNAO-UHFFFAOYSA-N

2.1.4 Canonical SMILES

C1CNCCC1C2=CC=CC=C2COC3=C(C=C(C=C3F)F)F

2.2 Other Identifiers

2.2.1 UNII

19997EZ42I

2.3 Synonyms

2.3.1 MeSH Synonyms

1. 4-(2-(2,4,6-trifluorophenoxymethyl)phenyl)piperidine

2. Td-9855

2.3.2 Depositor-Supplied Synonyms

1. Ampreloxetine [usan]

2. Td-9855

3. 1227056-84-9

4. 19997ez42i

5. 4-(2-(2,4,6-trifluorophenoxymethyl)phenyl)piperidine

6. 4-[2-(2,4,6-trifluorophenoxymethyl)phenyl]piperidine

7. Unii-19997ez42i

8. Ampreloxetine [inn]

9. Ampreloxetine (usan/inn)

10. Schembl2333436

11. Chembl4297646

12. Who 10867

13. Db15348

14. D11688

2.4 Create Date

2010-07-06

3 Chemical and Physical Properties

Molecular Formula	C₁₈H₁₈F₃NO
Molecular Weight	321.3 g/mol
XLogP3	3.8
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	5
Rotatable Bond Count	4
Exact Mass	321.13404868 g/mol
Monoisotopic Mass	321.13404868 g/mol
Topological Polar Surface Area	21.3 Å²
Heavy Atom Count	23
Formal Charge	0
Complexity	352
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1